furosemide and allopurinol

furosemide has been researched along with allopurinol in 37 studies

Research

Studies (37)

Timeframe	Studies, this research(%)	All Research%
pre-1990	4 (10.81)	18.7374
1990's	2 (5.41)	18.2507
2000's	12 (32.43)	29.6817
2010's	18 (48.65)	24.3611
2020's	1 (2.70)	2.80

Authors

Authors	Studies
Topliss, JG; Yoshida, F	1
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL	1
Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J	1
Lombardo, F; Obach, RS; Waters, NJ	1
Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM	1
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M	1
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV	1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A	1
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM	1
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV	1
García-Mera, X; González-Díaz, H; Prado-Prado, FJ	1
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ	1
Glen, RC; Lowe, R; Mitchell, JB	1
Ekins, S; Williams, AJ; Xu, JJ	1
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V	1
Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR	1
Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY	1
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ	1
Aleo, MD; Bonin, PD; Luo, Y; Potter, DM; Swiss, R; Will, Y	1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Jones, LH; Nadanaciva, S; Rana, P; Will, Y	1
Fuchs, D; Hermann, J; Plenert, W; Zintl, F	1
Dybing, E	1
Hirano, T; Kozaki, M; Oka, K; Tamaki, T; Toyoshima, Y	1
Chalopin, JM; Justrabo, E; Mousson, C; Rifle, G; Tanter, Y	1
Fenner, O; Kallistraos, G	1
Alonso-Ruiz, A; Calabozo, M; Duruelo, J; Perez-Ruiz, F	1
Hada, T; Moriwaki, Y; Takahashi, S; Tsutsumi, Z; Yamamoto, T	2
BenEzra, D; Francoz, N; Mauget-Fa, M; Mauget-Faÿsse, M; Quaranta, M	1
Acosta, GP; Cabrera, MS; Díaz, JG; Henríquez, MS; Hernández, LM; Quintana, PP; Salinas, RM	1
Hara, I; Kohjimoto, Y; Sasaki, Y	1
Barclay, ML; Chapman, PT; Drake, J; Frampton, C; O'Donnell, JL; Stamp, LK; Zhang, M	1
Bahn, A; Knake, C; Stamp, L	1
Gröbner, W	1
Coelho, VA; Costa, TEM; Elias, RM; Innecchi, MLR; Lauar, JC; Moysés, RMA	1
Saleem, M; Sultana, S	1

Reviews

3 review(s) available for furosemide and allopurinol

Article	Year
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016
Hypercalcemia worsened by the use of furosemide in a patient suffering from allopurinol-induced granulomatous hepatitis. Revista espanola de enfermedades digestivas, 2010, Volume: 102, Issue:2 Topics: Allopurinol; Chemical and Drug Induced Liver Injury; Diabetes Mellitus, Type 2; Diuretics; Fever; Furosemide; Gout Suppressants; Granuloma; Humans; Hypercalcemia; Hyperuricemia; Male; Middle Aged	2010
[Clinical strategies for prevention of drug-induced urinary calculi]. Clinical calcium, 2011, Volume: 21, Issue:10 Topics: Allopurinol; Anti-Bacterial Agents; Ascorbic Acid; Benzbromarone; Calcium; Calcium Compounds; Carbonic Anhydrase Inhibitors; Crystallization; Diuretics; Drug Combinations; Furosemide; Glucocorticoids; Humans; Magnesium Silicates; Oxalates; Protease Inhibitors; Purines; Time Factors; Triamterene; Urinary Calculi; Vitamin D	2011

Trials

2 trial(s) available for furosemide and allopurinol

Article	Year
Effect of furosemide on renal excretion of oxypurinol and purine bases. Metabolism: clinical and experimental, 2001, Volume: 50, Issue:2 Topics: Administration, Oral; Adult; Aldosterone; Allopurinol; Angiotensin II; Chlorides; Creatinine; Diuretics; Drug Therapy, Combination; Furosemide; Humans; Injections, Intravenous; Kidney; Male; Metabolic Clearance Rate; Middle Aged; Oxypurinol; Potassium; Purines; Sodium; Uric Acid; Xanthine Oxidase	2001
Furosemide increases plasma oxypurinol without lowering serum urate--a complex drug interaction: implications for clinical practice. Rheumatology (Oxford, England), 2012, Volume: 51, Issue:9 Topics: Adult; Aged; Allopurinol; Area Under Curve; Case-Control Studies; Diuretics; Drug Interactions; Drug Therapy, Combination; Female; Furosemide; Gout; Gout Suppressants; Humans; Male; Middle Aged; Oxypurinol; Treatment Outcome; Uric Acid; Urination	2012

Article

Year

Effect of furosemide on renal excretion of oxypurinol and purine bases.

Metabolism: clinical and experimental, 2001, Volume: 50, Issue:2

Topics: Administration, Oral; Adult; Aldosterone; Allopurinol; Angiotensin II; Chlorides; Creatinine; Diuretics; Drug Therapy, Combination; Furosemide; Humans; Injections, Intravenous; Kidney; Male; Metabolic Clearance Rate; Middle Aged; Oxypurinol; Potassium; Purines; Sodium; Uric Acid; Xanthine Oxidase

2001

Furosemide increases plasma oxypurinol without lowering serum urate--a complex drug interaction: implications for clinical practice.

Rheumatology (Oxford, England), 2012, Volume: 51, Issue:9

Topics: Adult; Aged; Allopurinol; Area Under Curve; Case-Control Studies; Diuretics; Drug Interactions; Drug Therapy, Combination; Female; Furosemide; Gout; Gout Suppressants; Humans; Male; Middle Aged; Oxypurinol; Treatment Outcome; Uric Acid; Urination

2012

Other Studies

32 other study(ies) available for furosemide and allopurinol

Article	Year
QSAR model for drug human oral bioavailability. Journal of medicinal chemistry, 2000, Jun-29, Volume: 43, Issue:13 Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship	2000
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling. Current drug discovery technologies, 2004, Volume: 1, Issue:4 Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration	2004
Chemical genetics reveals a complex functional ground state of neural stem cells. Nature chemical biology, 2007, Volume: 3, Issue:5 Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells	2007
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds. Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7 Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding	2008
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1. Journal of medicinal chemistry, 2008, Oct-09, Volume: 51, Issue:19 Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship	2008
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors. Journal of medicinal chemistry, 2008, Nov-13, Volume: 51, Issue:21 Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship	2008
Physicochemical determinants of human renal clearance. Journal of medicinal chemistry, 2009, Aug-13, Volume: 52, Issue:15 Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight	2009
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species. Chemical research in toxicology, 2010, Volume: 23, Issue:1 Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship	2010
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models. Toxicology mechanisms and methods, 2008, Volume: 18, Issue:2-3 Topics:	2008
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination. Journal of medicinal chemistry, 2010, Feb-11, Volume: 53, Issue:3 Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations	2010
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species. Bioorganic & medicinal chemistry, 2010, Mar-15, Volume: 18, Issue:6 Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics	2010
Developing structure-activity relationships for the prediction of hepatotoxicity. Chemical research in toxicology, 2010, Jul-19, Volume: 23, Issue:7 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes	2010
Predicting phospholipidosis using machine learning. Molecular pharmaceutics, 2010, Oct-04, Volume: 7, Issue:5 Topics: Animals; Artificial Intelligence; Databases, Factual; Drug Discovery; Humans; Lipidoses; Models, Biological; Phospholipids; Support Vector Machine	2010
A predictive ligand-based Bayesian model for human drug-induced liver injury. Drug metabolism and disposition: the biological fate of chemicals, 2010, Volume: 38, Issue:12 Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands	2010
FDA-approved drug labeling for the study of drug-induced liver injury. Drug discovery today, 2011, Volume: 16, Issue:15-16 Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration	2011
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions. Journal of medicinal chemistry, 2012, May-24, Volume: 55, Issue:10 Topics: Atorvastatin; Biological Transport; Drug Interactions; Estradiol; Estrone; HEK293 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Least-Squares Analysis; Liver; Liver-Specific Organic Anion Transporter 1; Models, Molecular; Multivariate Analysis; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Protein Isoforms; Pyrroles; Solute Carrier Organic Anion Transporter Family Member 1B3; Structure-Activity Relationship; Transfection	2012
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds. Chemical research in toxicology, 2012, Oct-15, Volume: 25, Issue:10 Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding	2012
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development. Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1 Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests	2013
Human drug-induced liver injury severity is highly associated with dual inhibition of liver mitochondrial function and bile salt export pump. Hepatology (Baltimore, Md.), 2014, Volume: 60, Issue:3 Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Chemical and Drug Induced Liver Injury; Humans; Male; Mitochondria, Liver; Rats; Rats, Sprague-Dawley; Severity of Illness Index	2014
Development of a cell viability assay to assess drug metabolite structure-toxicity relationships. Bioorganic & medicinal chemistry letters, 2016, 08-15, Volume: 26, Issue:16 Topics: Adenosine Triphosphate; Benzbromarone; Cell Line; Cell Survival; Chromans; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Humans; Pharmaceutical Preparations; Thiazolidinediones; Troglitazone	2016
[Basic therapy in children with leukemia and a malignant tumors. II]. Kinderarztliche Praxis, 1978, Volume: 46, Issue:3 Topics: Allopurinol; Anaphylaxis; Anemia; Antibiotics, Antineoplastic; Bicarbonates; Blood Transfusion; Child; Child, Preschool; Cystitis; Disseminated Intravascular Coagulation; Erythrocytes; Female; Furosemide; Heart Arrest; Heparin; Humans; Hydrogen-Ion Concentration; Kidney; Leukemia; Lung Diseases; Male; Mercaptopurine; Mutation; Neoplasms; Phospholipids; Renal Dialysis; Thrombocytopenia; Uric Acid	1978
Methyldopa binding to cells in culture. Acta pharmacologica et toxicologica, 1977, Volume: 40, Issue:1 Topics: Acetaminophen; Allopurinol; Animals; Ascorbic Acid; Carcinoma, Hepatocellular; Cells, Cultured; Deferoxamine; Dimethylnitrosamine; Edetic Acid; Furosemide; Glutathione; Liver Neoplasms; Maleates; Methyldopa; Neoplasms, Experimental; Protein Binding; Rats; Superoxide Dismutase; Time Factors; Xanthines	1977
Promotion of lymphocyte blastogenesis by hemodialysate of chronic renal failure. Nephron, 1992, Volume: 61, Issue:1 Topics: Allopurinol; Anabolic Agents; Androstanols; Calcitriol; Cells, Cultured; Concanavalin A; Creatinine; DNA Replication; Female; Furosemide; Humans; Kidney Failure, Chronic; Lectins; Lymphocyte Activation; Lymphocytes; Male; Middle Aged; Nifedipine; Reference Values; Renal Dialysis; Thymidine; Time Factors	1992
[Acute granulomatous interstitial nephritis and hepatitis caused by drugs. Possible role of an allopurinol-furosemide combination]. Nephrologie, 1986, Volume: 7, Issue:5 Topics: Acute Disease; Allopurinol; Atenolol; Biopsy; Chemical and Drug Induced Liver Injury; Female; Furosemide; Granuloma; Humans; Middle Aged; Nephritis, Interstitial	1986
[Recent observations on the drug treatment of renal lithiasis. Physico-chemical and biological bases]. Munchener medizinische Wochenschrift (1950), 1971, Aug-27, Volume: 113, Issue:35 Topics: Administration, Oral; Allopurinol; Ammonium Chloride; Anti-Bacterial Agents; Chemical Phenomena; Chemistry, Physical; Citrates; Diet Therapy; Female; Fibrinolytic Agents; Furosemide; Humans; Infusions, Parenteral; Ion Exchange; Kidney Calculi; Male; Potassium Chloride; Pyruvates; Therapeutic Irrigation; Urine; Vitamins	1971
Treatment of gout after transplantation. British journal of rheumatology, 1998, Volume: 37, Issue:5 Topics: Allopurinol; Azathioprine; Cyclosporine; Diuretics; Drug Interactions; Furosemide; Gout; Gout Suppressants; Heart Transplantation; Humans; Postoperative Complications; Uric Acid	1998
Incidental retinal phototoxicity associated with ingestion of photosensitizing drugs. Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie, 2001, Volume: 239, Issue:7 Topics: Aged; Allopurinol; Benzodiazepines; Female; Fluorescein Angiography; Furosemide; Humans; Hydrochlorothiazide; Indocyanine Green; Light; Male; Middle Aged; Photosensitizing Agents; Radiation Injuries; Retina; Scotoma; Visual Acuity	2001
Effect of losartan and furosemide on the urinary excretion of oxypurinol and uric acid. Advances in experimental medicine and biology, 2000, Volume: 486 Topics: Adult; Angiotensin Receptor Antagonists; Antihypertensive Agents; Blood Proteins; Diuretics; Furosemide; Humans; Losartan; Male; Middle Aged; Oxypurinol; Uric Acid; Xanthine Oxidase	2000
Molecular mechanism of an adverse drug-drug interaction of allopurinol and furosemide in gout treatment. Biochemical and biophysical research communications, 2014, Sep-12, Volume: 452, Issue:1 Topics: Allopurinol; Cell Line; Drug Interactions; Furosemide; Gout; Humans	2014
[Hyperuricemia and gout]. Deutsche medizinische Wochenschrift (1946), 2015, Volume: 140, Issue:21 Topics: Allopurinol; Arthritis, Gouty; Colchicine; Diagnosis, Differential; Drug Therapy, Combination; Furosemide; Gout; Humans; Hyperuricemia; Life Style; Male; Middle Aged	2015
Hyperuricemia is associated with secondary hyperparathyroidism in patients with chronic kidney disease. International urology and nephrology, 2022, Volume: 54, Issue:9 Topics: Adult; Aged; Aged, 80 and over; Allopurinol; Calcium; Cholecalciferol; Female; Furosemide; Humans; Hyperparathyroidism, Secondary; Hyperuricemia; Male; Middle Aged; Parathyroid Hormone; Phosphates; Renal Insufficiency, Chronic; Retrospective Studies; Uric Acid; Vitamin D; Vitamin D Deficiency	2022
Salix caprea inhibits skin carcinogenesis in murine skin: inhibition of oxidative stress, ornithine decarboxylase activity and DNA synthesis. Journal of ethnopharmacology, 2004, Volume: 91, Issue:2-3 Topics: Administration, Cutaneous; Animals; Anticarcinogenic Agents; Dose-Response Relationship, Drug; Female; Flowers; Mice; Ornithine Decarboxylase; Oxidative Stress; Phytotherapy; Plant Extracts; Salix; Skin; Skin Neoplasms; Tetradecanoylphorbol Acetate; Xanthine Oxidase	2004